Centurion Accommodation REIT (CAREIT): Robust Performance and Growth Updates Post SGX Listing

SGX-ST Mainboard Listing Success

• CAREIT was successfully listed on the SGX-ST Mainboard on 25 September 2025, attracting strong institutional and retail investor demand with an overall subscription rate of ~16.6x.
• International institutional investors, specialist real estate funds, and high net-worth individuals showed robust interest.
• 16 cornerstone investors subscribed to ~35.7% of total Units, with the placement tranche ~16.0x subscribed and Singapore Public Offer ~30.9x subscribed.
• Units closed 9.1% above issue price at S\$0.96 per unit on listing day, with exceptional trading liquidity, peaking at 36.7 million units traded in September 2025.

Strong Financial Performance Exceeding Forecasts

• Revenue: S\$50.7 million, up 3.4% over forecast.
• Net Property Income (NPI): S\$36.1 million, up 4.1% over forecast, driven by higher rental rates and occupancy across both PBWA and PBSA portfolios.
• Distribution Per Unit (DPU): 1.739 cents, 6.7% above forecast (1.630 cents).
• Finance Costs: 17.6% below forecast due to lower loan drawdown and favorable interest rates.
• Annualized Distribution Yield: 5.84% based on closing price of S\$1.11 per unit, outperforming major Singapore REIT and equity indices.

Portfolio Updates and Expansion Milestones

• Westlite Toh Guan: New block (c.1,764 beds) received TOP on 25 Oct 2025 and FEDA license on 5 Dec 2025. Approval to retain c.664 beds until end-2028.
• Westlite Mandai: New block (c.3,696 beds) received TOP on 7 Jan 2026. Approval to retain c.1,980 beds until end-2030. S\$34.0m consideration payable upon operational milestone by mid-2026.
• Westlite Ubi: Provisional permission to develop 6-storey block (c.540 beds), targeting commencement in 1H 2026, with 1.5 years construction timeline.
• Epiisod Macquarie Park, Australia: Acquisition of 732-bed PBSA asset completed in Jan 2026, fully financed via committed debt. Master Lease provides fixed rental of A\$14.1m for FY2026 and A\$20.0m for FY2027.

Capital Management and Debt Profile

• Aggregate Leverage: 30.7% post-acquisition, with significant debt headroom (S\$348m at 40% gearing).
• Weighted Average Financing Cost: 3.46% (excluding amortisation), below forecast.
• No debt maturities until FY2028. Debt drawn in local currencies for natural hedging.
• Interest Coverage Ratio: 6.60x, demonstrating strong financial resilience.
• Debt diversification across SGD, AUD, and GBP.

Portfolio Overview

• Portfolio valuation stands at S\$1.88 billion, spanning 14 operational properties across Singapore, UK, and Australia, with c.25,154 operational beds and high occupancy rates (PBWA 97.6%, PBSA 99.1%).
• Singapore PBWA accounts for 77.06% of portfolio value; UK PBSA 20.13%; Australia 2.81%.
• Leasehold tenure is robust, with 84.5% of assets having more than 30 years remaining.
• Revenue concentration risk is low; top 10 tenants contribute only 7.26% of gross rental income, with 79% derived from the construction sector.
• UK PBSA is predominantly domestic-led; Australia PBSA is internationally driven (97% international students).

Industry Recognition and Sustainability

• CAREIT has received multiple awards including IFR Asia Awards 2025 (Singapore Capital Markets Deal of the Year), The Asset Triple A Awards for Sustainable Finance 2026 (Significant Deal, Best IPO Award).
• CAREIT is now included in key indices: FTSE ASEAN All-Share, MSCI Singapore Small Cap, Morningstar Global REIT, among others.
• Westlite Woodlands and Westlite Toh Guan achieved Level 2 EDGE Advanced sustainability certification.

Market Outlook

• Singapore: CMP Work Permit holders rose to 460,300 by June 2025 (+0.8% YoY). BCA projects S\$47-53 billion construction demand in 2026, driven by major infrastructure projects.
• Supply Constraints: Enhanced regulatory standards, land availability, and zoning continue to restrict dormitory supply. Only 45,000 new beds expected in coming years.
• UK: Domestic student demand remains robust, with acceptances and applicants rising for AY2025/26 and AY2026/27. Supply growth is moderating, with only a 1% increase in PBSA beds in 2025.
• Australia: International enrolments surged 17.7% in 2024, outpacing a structurally undersupplied PBSA market.

Strategic Framework for Growth

• CAREIT pursues proactive asset management, organic growth, asset enhancement, and redevelopment opportunities to maintain high occupancy and rental rates.
• Prudent capital and risk management, with proactive interest rate and currency hedging.
• Accretive acquisitions from both sponsor and third parties, supported by a clear investment mandate and strong pipeline visibility.
• Sponsor (Centurion Corporation Ltd) holds significant (42.8%) stake, ensuring alignment and access to additional assets via Right of First Refusal.

Shareholder Considerations & Potential Price-Sensitive Information

• CAREIT’s strong operational performance and higher-than-expected DPU may positively influence share values.
• Major portfolio expansions with new beds and acquisitions, as well as robust capital management and debt headroom, position CAREIT for future growth.
• Outstanding awards, index inclusions, and sustainability certifications further enhance CAREIT’s profile with institutional investors.
• Significant forthcoming milestones relating to expanded bed capacity and regulatory approvals (Mandai, Toh Guan, Ubi) could materially impact revenue and future distributions.
• Potential S\$34m consideration payable for Mandai Expanded Capacity upon operational milestone by mid-2026 could affect cash flows and share price upon realization.

Distribution Details

• Distribution per unit for the period from 25 Sep to 31 Dec 2025 is 1.739 Singapore cents.
• Distribution payment date: 31 March 2026.
• DPU comprises taxable income, tax-exempt income, and capital distribution.
• Annualised yield is competitive versus Singapore REIT indices and government bonds.

Conclusion

CAREIT’s debut on SGX-ST has been marked by resilient financial performance, strategic portfolio expansion, robust capital management, and industry recognition. With favorable sector fundamentals and a clear growth strategy, CAREIT is well-positioned for continued value creation. Investors should monitor upcoming operational milestones and regulatory approvals, which may be price-sensitive and impact future distributions and share price.

Disclaimer

This article is for informational purposes only and does not constitute investment advice. Investors are advised to conduct their own due diligence and consult professional advisors before making any investment decisions. The information is based on the latest available financial report and may be subject to change. Past performance is not indicative of future results.

View Cent Accom REIT Historical chart here